Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes
- 28 January 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 301 (4), 985-990
- https://doi.org/10.1016/s0006-291x(03)00074-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The AcrAB-TolC Efflux Pump Contributes to Multidrug Resistance in the Nosocomial Pathogen Enterobacter aerogenesAntimicrobial Agents and Chemotherapy, 2002
- Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strainsBiochemical and Biophysical Research Communications, 2002
- Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination TherapyAntimicrobial Agents and Chemotherapy, 2001
- Direct Quantitative Transcript Analysis of the agr Regulon of Staphylococcus aureus during Human Infection in Comparison to the Expression Profile In VitroInfection and Immunity, 2000
- Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenesMicrobiology, 1998
- Outer Membrane Profiles of Clonally Related Klebsiella pneumoniae Isolates from Clinical Samples and Activities of Cephalosporins and CarbapenemsAntimicrobial Agents and Chemotherapy, 1998
- Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenesJournal of Medical Microbiology, 1994
- Imipenem resistance inEnterobacter aerogenesis associated with derepression of chromosomal cephalosporinases and impaired permeabilityFEMS Microbiology Letters, 1992
- Carbapenem Resistance in Enterobacter aerogenes is due to Lipopolysaccharide AlterationsChemotherapy, 1991
- Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenesJournal of Antimicrobial Chemotherapy, 1990